MemorEM

DEVICE3 trials

Sponsors

NeuroEM Therapeutics, Inc., eQ8Health Corporation d/b/a CareONE Concierge

Conditions

Alzheimer DiseaseAlzheimer's DiseaseAlzheimer's DiseaseCortico Basal DegenerationDementiaFronto-temporal DementiaFrontotemporal DementiaNeurological Diseases or Conditions

Phase 1

Transcranial Electromagnetic Treatment (TEMT) Against Alzheimer's Disease

NeuroEM Therapeutics, Inc.Alzheimer's Disease

Start: 2020-02-10End: 2021-03-31Updated: 2020-02-17

Unknown Phase

Pilot Trial Evaluating Patient Experience With the MemorEM for Patients With Neurological Diseases

Enrolling by invitationNCT07049341

NeuroEM Therapeutics, Inc.Alzheimer's Disease, Cortico Basal Degeneration, Fronto-temporal Dementia +3

Start: 2025-07-31End: 2028-06-30Target: 100Updated: 2025-08-05

Research Study for Patients With Neurological Diseases Which Evaluates the Patient Experience of the MemorEM Device

Enrolling by invitationNCT07222605

eQ8Health Corporation d/b/a CareONE ConciergeAlzheimer Disease, Cortico Basal Degeneration, Dementia +4

Start: 2025-12-01End: 2029-12-15Target: 1000Updated: 2026-02-05